← Open Payments lookup

DENISE JOHNSON: Open Payments

NPI 1124226147 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,723 in 67 payments from 15 companies in 2025. Trend: 2023 $1,800 · 2024 $1,952 · 2025 $1,723

Food & beverage: $1,723
CompanyPaymentsAmount
GENZYME CORPORATION13$355
AstraZeneca Pharmaceuticals LP16$349
PFIZER INC.8$198
Genentech USA, Inc.4$129
Takeda Pharmaceuticals U.S.A., Inc.4$113
Novartis Pharmaceuticals Corporation5$107
Boston Scientific Corporation1$104
Regeneron Healthcare Solutions, Inc.4$95
GlaxoSmithKline, LLC.4$92
Amgen Inc.3$71

Products named: DUPIXENT, TEZSPIRE, Xolair, FASENRA, CIBINQO, ENROUTE Transcarotid Neuroprotection System, CUVITRU, TRELEGY ELLIPTA.

Industry payments across MD — which companies pay providers there.